IRadimed Corp (IRMD) stock
IRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3054% above fair value
$83.45−1.39 (-1.64%)
Close on Nov 17, 2026Market cap $1.07BP/E 44.6Yield –
IRadimed operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
IRadimed's operating cash flow for the twelve months ending Sep 30, 2026 was $27.15M, up 8.5% year over year. For fiscal 2025 it was $24.95M, down 2.6% from the year before. Over ten years it grew 12.5% a year on average. The highest annual figure on record is $25.62M in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.95M | -2.6% |
| FY2024 | Dec 31, 2024 | $25.62M | +90.3% |
| FY2023 | Dec 31, 2023 | $13.47M | +34.1% |
| FY2022 | Dec 31, 2022 | $10.04M | -10.8% |
| FY2021 | Dec 31, 2021 | $11.26M | +93.5% |
| FY2020 | Dec 31, 2020 | $5.82M | -43.1% |
| FY2019 | Dec 31, 2019 | $10.23M | +38.7% |
| FY2018 | Dec 31, 2018 | $7.38M | +115.9% |
| FY2017 | Dec 31, 2017 | $3.42M | -63.7% |
| FY2016 | Dec 31, 2016 | $9.41M | +23.0% |
| FY2015 | Dec 31, 2015 | $7.65M | +195.8% |
| FY2014 | Dec 31, 2014 | $2.59M | +75.4% |
| FY2013 | Dec 31, 2013 | $1.47M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $7.00M | +0.2% |
| Q2 FY2026 | Jun 30, 2026 | $5.94M | -23.3% |
| Q1 FY2026 | Mar 31, 2026 | $8.29M | +93.2% |
| Q4 FY2025 | Dec 31, 2025 | $5.92M | -1.1% |
| Q3 FY2025 | Sep 30, 2025 | $6.99M | -23.4% |
| Q2 FY2025 | Jun 30, 2025 | $7.75M | +16.7% |
| Q1 FY2025 | Mar 31, 2025 | $4.29M | +10.5% |
| Q4 FY2024 | Dec 31, 2024 | $5.99M | +53.0% |
| Q3 FY2024 | Sep 30, 2024 | $9.12M | +554.5% |
| Q2 FY2024 | Jun 30, 2024 | $6.64M | +88.9% |
| Q1 FY2024 | Mar 31, 2024 | $3.88M | -16.4% |
| Q4 FY2023 | Dec 31, 2023 | $3.91M | +28.7% |
| Q3 FY2023 | Sep 30, 2023 | $1.39M | -64.6% |
| Q2 FY2023 | Jun 30, 2023 | $3.51M | +114.4% |
| Q1 FY2023 | Mar 31, 2023 | $4.65M | +225.8% |
| Q4 FY2022 | Dec 31, 2022 | $3.04M | -9.7% |
| Q3 FY2022 | Sep 30, 2022 | $3.94M | +16.6% |
| Q2 FY2022 | Jun 30, 2022 | $1.64M | -54.1% |
| Q1 FY2022 | Mar 31, 2022 | $1.43M | +51.2% |
| Q4 FY2021 | Dec 31, 2021 | $3.37M | +34.9% |
| Q3 FY2021 | Sep 30, 2021 | $3.38M | +153.2% |
| Q2 FY2021 | Jun 30, 2021 | $3.57M | +351.6% |
| Q1 FY2021 | Mar 31, 2021 | $943.08K | -21.2% |
| Q4 FY2020 | Dec 31, 2020 | $2.50M | -36.8% |
| Q3 FY2020 | Sep 30, 2020 | $1.33M | -57.5% |
| Q2 FY2020 | Jun 30, 2020 | $790.60K | -68.1% |
| Q1 FY2020 | Mar 31, 2020 | $1.20M | +79.9% |
| Q4 FY2019 | Dec 31, 2019 | $3.95M | +11.5% |
| Q3 FY2019 | Sep 30, 2019 | $3.14M | +331.1% |
| Q2 FY2019 | Jun 30, 2019 | $2.48M | +63.0% |
| Q1 FY2019 | Mar 31, 2019 | $665.20K | -58.0% |
| Q4 FY2018 | Dec 31, 2018 | $3.54M | +152.8% |
| Q3 FY2018 | Sep 30, 2018 | $727.93K | -61.8% |
| Q2 FY2018 | Jun 30, 2018 | $1.52M | +422.0% |
| Q1 FY2018 | Mar 31, 2018 | $1.58M | – |
| Q4 FY2017 | Dec 31, 2017 | $1.40M | -37.0% |
| Q3 FY2017 | Sep 30, 2017 | $1.91M | – |
| Q2 FY2017 | Jun 30, 2017 | $291.53K | – |
| Q1 FY2017 | Mar 31, 2017 | -$184.65K | – |
| Q4 FY2016 | Dec 31, 2016 | $2.22M | – |
See a number that looks wrong?